Computational analysis of expression of human embryonic stem cell-associated signatures in tumors

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Wang, Xiaosheng ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80054972525     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-471     Document Type: Article

References (178)

1. Stem cells, cancer, and cancer stem cells. Reya T, Morrison SJ, Clarke MF, Weissman IL, Nature 2001 414 6859 105 111 (Pubitemid 33041634)
2. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM, Cancer Res 2006 66 19 9339 9344 (Pubitemid 44623625)
3. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Bonnet D, Dick JE, Nat Med 1997 3 7 730 737 (Pubitemid 27298715)
4. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE, Nature 1994 367 6464 645 648 (Pubitemid 24067706)
5. The biology of cancer stem cells. Lobo NA, Shimono Y, Qian D, Clarke MF, Annu Rev Cell Dev Biol 2007 23 675 699
6. Identification of a cancer stem cell in human brain tumors. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB, Cancer Res 2003 63 18 5821 5828 (Pubitemid 37187480)
7. Identification of human brain tumour initiating cells. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB, Nature 2004 432 7015 396 401 (Pubitemid 39551674)
8. Prospective identification of tumorigenic breast cancer cells. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, Proc Natl Acad Sci USA 2003 100 7 3983 3988 (Pubitemid 36418143)
9. A tumorigenic subpopulation with stem cell properties in melanomas. Fang D, Nguyen TK, Leishear K, Finko R, Kulp AN, Hotz S, Van Belle PA, Xu X, Elder DE, Herlyn M, Cancer Res 2005 65 20 9328 9337 (Pubitemid 41508000)
10. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Zhang S, Balch C, Chan MW, Lai H-C, Matei D, Schilder JM, Yan PS, Huang THM, Nephew KP, Cancer Res 2008 68 11 4311 4320
11. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Bapat SA, Mali AM, Koppikar CB, Kurrey NK, Cancer Res 2005 65 8 3025 3029 (Pubitemid 40524578)
12. Prospective identification of tumorigenic prostate cancer stem cells. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, Cancer Res 2005 65 23 10946 10951 (Pubitemid 41713363)
13. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Marion RM, Strati K, Li H, Tejera A, Schoeftner S, Ortega S, Serrano M, Blasco MA, Cell Stem Cell 2009 4 2 141 154
14. Identification of pancreatic cancer stem cells. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM, Cancer Res 2007 67 3 1030 1037
15. Stem-like cells in bone sarcomas: implications for tumorigenesis. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, Steindler DA, Neoplasia 2005 7 11 967 976
16. Identification and expansion of human colon-cancer-initiating cells. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R, Nature 2007 445 7123 111 115 (Pubitemid 46067311)
17. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. O'Brien CA, Pollett A, Gallinger S, Dick JE, Nature 2007 445 7123 106 110 (Pubitemid 46067310)
18. Cancer stem cells: mirage or reality? Gupta PB, Chaffer CL, Weinberg RA, Nature medicine 2009 15 9 1010 1012
19. Tumor growth need not be driven by rare cancer stem cells. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A, Science (New York, N Y) 2007 317 5836 337 (Pubitemid 47106366)
20. Comment on "Tumor growth need not be driven by rare cancer stem cells". Kennedy JA, Barabe F, Poeppl AG, Wang JCY, Dick JE, Science (New York, N Y) 2007 318 5857 1722 author reply 1722
21. Efficient tumour formation by single human melanoma cells. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ, Nature 2008 456 7222 593 598
22. The tumorigenicity of human embryonic and induced pluripotent stem cells. Ben-David U, Benvenisty N, Nat Rev Cancer 2011 11 4 268 277
23. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S, Cell 2007 131 5 861 872 (Pubitemid 350138099)
24. Induced pluripotent stem cell lines derived from human somatic cells. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA, Science (New York, N Y) 2007 318 5858 1917 1920
25. The Myc oncoprotein as a therapeutic target for human cancer. Vita M, Henriksson M, Semin Cancer Biol 2006 16 4 318 330 (Pubitemid 44311040)
26. Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes. Lambertini C, Pantano S, Dotto GP, PLoS One 2010 5 4 10369
27. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Peng S, Maihle NJ, Huang Y, Oncogene 2010 29 14 2153 2159
28. Expression of Sox2 in human cervical carcinogenesis. Ji J, Zheng P-S, Hum Pathol 2010 41 10 1438 1447
29. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Chiou S-H, Yu C-C, Huang C-Y, Lin S-C, Liu C-J, Tsai T-H, Chou S-H, Chien C-S, Ku H-H, Lo J-F, Clin Cancer Res 2008 14 13 4085 4095
30. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Kawamura T, Suzuki J, Wang YV, Menendez S, Morera LB, Raya A, Wahl GM, Belmonte JCI, Nature 2009 460 7259 1140 1144
31. Telomeres, stem cells, senescence, and cancer. Sharpless NE, DePinho RA, J Clin Invest 2004 113 2 160 168 (Pubitemid 38544198)
32. Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S, Epigenetics 2011 6 1 63 75
33. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM, Proc Natl Acad Sci USA 1994 91 21 9857 9860 (Pubitemid 24311907)
34. Telomeres and telomerase in cancer. Artandi SE, DePinho RA, Carcinogenesis 2010 31 1 9 18
35. Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. Ghule PN, Medina R, Lengner CJ, Mandeville M, Qiao M, Dominski Z, Lian JB, Stein JL, van Wijnen AJ, Stein GS, J Cell Physiol 2011 226 5 1149 1156
36. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Singh AM, Dalton S, Cell Stem Cell 2009 5 2 141 149
37. Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells. Neganova I, Zhang X, Atkinson S, Lako M, Oncogene 2009 28 1 20 30
38. The cell cycle and cancer. Collins K, Jacks T, Pavletich NP, Proc Natl Acad Sci USA 1997 94 7 2776 2778 (Pubitemid 27157209)
39. Cell cycle control and cancer. Hartwell LH, Kastan MB, Science 1994 266 5192 1821 1828
40. Gene expression in human embryonic stem cell lines: unique molecular signature. Bhattacharya B, Miura T, Brandenberger R, Mejido J, Luo Y, Yang AX, Joshi BH, Ginis I, Thies RS, Amit M, Lyons I, Condie BG, Itskovitz-Eldor J, Rao MS, Puri RK, Blood 2004 103 8 2956 2964 (Pubitemid 38451667)
41. Unique gene expression signatures of independently-derived human embryonic stem cell lines. Abeyta MJ, Clark AT, Rodriguez RT, Bodnar MS, Pera RAR, Firpo MT, Hum Mol Genet 2004 13 6 601 608 (Pubitemid 38386590)
42. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, Brooks JD, Andrews PW, Brown PO, Thomson JA, Proc Natl Acad Sci USA 2003 100 23 13350 13355 (Pubitemid 37444745)
43. Core transcriptional regulatory circuitry in human embryonic stem cells. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA, Cell 2005 122 6 947 956 (Pubitemid 41345211)
44. An extended transcriptional network for pluripotency of embryonic stem cells. Kim J, Chu J, Shen X, Wang J, Orkin SH, Cell 2008 132 6 1049 1061 (Pubitemid 351381745)
45. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou M-F, de Tribolet N, Regli L, Wick W, Kouwenhoven MCM, Hainfellner JA, Heppner FL, Dietrich P-Y, Zimmer Y, Cairncross JG, Janzer R-C, Domany E, Delorenzi M, Stupp R, Hegi ME, J Clin Oncol 2008 26 18 3015 3024
46. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Santagata S, Ligon KL, Hornick JL, Am J Surg Pathol 2007 31 6 836 845 (Pubitemid 47165136)
47. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA, Nature genetics 2008 40 5 499 507 (Pubitemid 351601215)
48. An embryonic stem cell-like signature identifies poorly differentiated lung adenocarcinoma but not squamous cell carcinoma. Hassan KA, Chen G, Kalemkerian GP, Wicha MS, Beer DG, Clinical cancer research: an official journal of the American Association for Cancer Research 2009 15 20 6386 6390
49. Embryonic stem cell markers expression in cancers. Schoenhals M, Kassambara A, De Vos J, Hose D, Moreaux J, Klein B, Biochem Biophys Res Commun 2009 383 2 157 162
50. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management. Glinsky GV, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008 26 17 2846 2853
51. BRB-ArrayTools Data Archive for human cancer gene expression: A unique and efficient data sharing resource. Zhao Y, Simon R, Cancer Inform 2008 6 9 15
52. Control of the embryonic stem cell state. Young RA, Cell 2011 144 6 940 954
53. MicroRNAs: key regulators of stem cells. Gangaraju VK, Lin H, Nat Rev Mol Cell Biol 2009 10 2 116 125
54. Analysis of Gene Expression Data Using BRB-Array Tools. Simon R, Lam A, Li M-C, Ngan M, Menenzes S, Zhao Y, Cancer Informatics 2007 3 11 17 (Pubitemid 47075796)
55. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Hu G, Kim J, Xu Q, Leng Y, Orkin SH, Elledge SJ, Genes Dev 2009 23 7 837 848
56. Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. Kashyap V, Rezende NC, Scotland KB, Shaffer SM, Persson JL, Gudas LJ, Mongan NP, Stem Cells Dev 2009 18 7 1093 1108
57. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Card DAG, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, Archer TK, Molecular and cellular biology 2008 28 20 6426 6438
58. A data integration approach to mapping OCT4 gene regulatory networks operative in embryonic stem cells and embryonal carcinoma cells. Jung M, Peterson H, Chavez L, Kahlem P, Lehrach H, Vilo J, Adjaye J, PLoS One 2010 5 5 10709
59. Evolutionarily conserved transcriptional co-expression guiding embryonic stem cell differentiation. Sun Y, Li H, Liu Y, Mattson MP, Rao MS, Zhan M, PLoS One 2008 3 10 3406
60. Signalling, cell cycle and pluripotency in embryonic stem cells. Burdon T, Smith A, Savatier P, Trends in cell biology 2002 12 9 432 438 (Pubitemid 35239952)
61. Chloride ions control the G1/S cell-cycle checkpoint by regulating the expression of p21 through a p53-independent pathway in human gastric cancer cells. Miyazaki H, Shiozaki A, Niisato N, Ohsawa R, Itoi H, Ueda Y, Otsuji E, Yamagishi H, Iwasaki Y, Nakano T, Nakahari T, Marunaka Y, Biochem Biophys Res Commun 2008 366 2 506 512 (Pubitemid 50012763)
62. G1 cell-cycle control and cancer. Massague J, Nature 2004 432 7015 298 306 (Pubitemid 39551657)
63. Defects in G1-S cell cycle control in head and neck cancer: A review. Michalides RJAM, van de Brekel M, Balm F, Head Neck 2002 24 7 694 704 (Pubitemid 34734366)
64. G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview. Niklinska W, Laudanski J, Niklinski J, Neoplasma 2001 48 3 157 163 (Pubitemid 32678678)
65. To cycle or not to cycle: A critical decision in cancer. Malumbres M, Barbacid M, Nat Rev Cancer 2001 1 3 222 231 (Pubitemid 33741897)
66. Concise review: regulation of embryonic stem cell lineage commitment by mitogen-activated protein kinases. Binetruy B, Heasley L, Bost F, Caron L, Aouadi M, Stem Cells 2007 25 5 1090 1095 (Pubitemid 46684867)
67. Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Wang L, Schulz TC, Sherrer ES, Dauphin DS, Shin S, Nelson AM, Ware CB, Zhan M, Song C-Z, Chen X, Brimble SN, McLean A, Galeano MJ, Uhl EW, D'Amour KA, Chesnut JD, Rao MS, Blau CA, Robins AJ, Blood 2007 110 12 4111 4119 (Pubitemid 350248470)
68. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T, Ramos-Mejia V, Rouleau A, Yang J, Bosse M, Lajoie G, Bhatia M, Nature 2007 448 7157 1015 1021 (Pubitemid 47345578)
69. MPSS profiling of human embryonic stem cells. Brandenberger R, Khrebtukova I, Thies RS, Miura T, Jingli C, Puri R, Vasicek T, Lebkowski J, Rao M, BMC Dev Biol 2004 4 10
70. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. Celil AB, Campbell PG, The Journal of biological chemistry 2005 280 36 31353 31359 (Pubitemid 41291875)
71. Insulin-like growth factor and lung cancer. Velcheti V, Govindan R, J Thorac Oncol 2006 1 7 607 610 (Pubitemid 47163945)
72. Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy. Izycki T, Chyczewska E, Naumnik W, Talalaj J, Panek B, Ossolinska M, Exp Oncol 2004 26 4 316 319
73. Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. Hsieh A, Ellsworth R, Hsieh D, J Cell Physiol 2011 226 4 1118 1127
74. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Guvakova MA, Surmacz E, Cancer Res 1997 57 13 2606 2610 (Pubitemid 27283767)
75. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Anisimov VN, Exp Gerontol 2003 38 10 1041 1049 (Pubitemid 37324415)
76. IGF signaling pathway as a selective target of familial breast cancer therapy. Shukla V, Coumoul X, Vassilopoulos A, Deng C-X, Curr Mol Med 2008 8 8 727 740
77. Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. Vanamala J, Reddivari L, Radhakrishnan S, Tarver C, BMC Cancer 2010 10 238
78. Basic fibroblast growth factor activates ERK and induces c-fos in human embryonic stem cell line MizhES1. Kang HB, Kim JS, Kwon H-J, Nam KH, Youn HS, Sok D-E, Lee Y, Stem Cells Dev 2005 14 4 395 401 (Pubitemid 41243702)
79. Molecular mechanisms involved in self-renewal and pluripotency of embryonic stem cells. Liu N, Lu M, Tian X, Han Z, J Cell Physiol 2007 211 2 279 286 (Pubitemid 46580081)
80. Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Levenstein ME, Ludwig TE, Xu R-H, Llanas RA, VanDenHeuvel-Kramer K, Manning D, Thomson JA, Stem Cells 2006 24 3 568 574 (Pubitemid 44464760)
81. Expression and potential role of fibroblast growth factor 2 and its receptors in human embryonic stem cells. Dvorak P, Dvorakova D, Koskova S, Vodinska M, Najvirtova M, Krekac D, Hampl A, Stem Cells 2005 23 8 1200 1211 (Pubitemid 41377735)
82. Targeting the RAF-MEK-ERK pathway in cancer therapy. Montagut C, Settleman J, Cancer Lett 2009 283 2 125 134
83. Applying the principles of stem-cell biology to cancer. Pardal R, Clarke MF, Morrison SJ, Nat Rev Cancer 2003 3 12 895 902 (Pubitemid 37500174)
84. Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells. Babaie Y, Herwig R, Greber B, Brink TC, Wruck W, Groth D, Lehrach H, Burdon T, Adjaye J, Stem Cells 2007 25 2 500 510 (Pubitemid 46232806)
85. WNT signaling pathway and stem cell signaling network. Katoh M, Katoh M, Clinical cancer research: an official journal of the American Association for Cancer Research 2007 13 14 4042 4045 (Pubitemid 47105963)
86. Stem cell origin of cancer and differentiation therapy. Sell S, Crit Rev Oncol Hematol 2004 51 1 1 28 (Pubitemid 38781748)
87. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Liu S, Dontu G, Mantle ID, Patel S, Ahn N-s, Jackson KW, Suri P, Wicha MS, Cancer research 2006 66 12 6063 6071
88. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Williams JA, Guicherit OM, Zaharian BI, Xu Y, Chai L, Wichterle H, Kon C, Gatchalian C, Porter JA, Rubin LL, Wang FY, Proc Natl Acad Sci USA 2003 100 8 4616 4621 (Pubitemid 36457779)
89. Sonic hedgehog pathway is essential for maintenance of cancer stem-like cells in human gastric cancer. Song Z, Yue W, Wei B, Wang N, Li T, Guan L, Shi S, Zeng Q, Pei X, Chen L, PLoS One 2011 6 3 17687
90. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. Mimeault M, Hauke R, Mehta PP, Batra SK, J Cell Mol Med 2007 11 5 981 1011 (Pubitemid 350037046)
91. Hedgehog signaling and therapeutics in pancreatic cancer. Kelleher FC, Carcinogenesis 2011 32 4 445 451
92. Activating Smoothened mutations in sporadic basal-cell carcinoma. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH, de Sauvage FJ, Nature 1998 391 6662 90 92 (Pubitemid 28079221)
93. The role of hedgehog signalling in tumorigenesis. Wicking C, McGlinn E, Cancer Lett 2001 173 1 1 7 (Pubitemid 32907502)
94. Crosstalk of hedgehog and Wnt pathways in gastric cancer. Yanai K, Nakamura M, Akiyoshi T, Nagai S, Wada J, Koga K, Noshiro H, Nagai E, Tsuneyoshi M, Tanaka M, Katano M, Cancer Lett 2008 263 1 145 156
95. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, Nat Med 2004 10 1 55 63 (Pubitemid 38524699)
96. Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cells. Mallanna SK, Rizzino A, Dev Biol 2010 344 1 16 25
97. In silico identification of a core regulatory network of OCT4 in human embryonic stem cells using an integrated approach. Chavez L, Bais AS, Vingron M, Lehrach H, Adjaye J, Herwig R, BMC genomics 2009 10 314
98. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. James D, Levine AJ, Besser D, Hemmati-Brivanlou A, Development 2005 132 6 1273 1282 (Pubitemid 40528787)
99. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. Besser D, The Journal of biological chemistry 2004 279 43 45076 45084 (Pubitemid 39430922)
100. Gene expression profiling of embryonic stem cells leads to greater understanding of pluripotency and early developmental events. Rao RR, Stice SL, Biol Reprod 2004 71 6 1772 1778 (Pubitemid 39586919)
101. Transcriptional profiling of the developmentally important signalling pathways in human embryonic stem cells. Rho J-Y, Yu K, Han J-S, Chae J-I, Koo D-B, Yoon H-S, Moon S-Y, Lee K-K, Han Y-M, Hum Reprod 2006 21 2 405 412 (Pubitemid 43159915)
102. The transcriptome profile of human embryonic stem cells as defined by SAGE. Richards M, Tan S-P, Tan J-H, Chan W-K, Bongso A, Stem Cells 2004 22 1 51 64 (Pubitemid 38018781)
103. Wnt signalling in stem cells and cancer. Reya T, Clevers H, Nature 2005 434 7035 843 850 (Pubitemid 40558990)
104. Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis. Carethers JM, Gastroenterology 2009 137 1 33 36
105. The Hedgehog and Wnt signalling pathways in cancer. Taipale J, Beachy PA, Nature 2001 411 6835 349 354 (Pubitemid 32467044)
106. Tissue repair and stem cell renewal in carcinogenesis. Beachy PA, Karhadkar SS, Berman DM, Nature 2004 432 7015 324 331 (Pubitemid 39551660)
107. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, Duale N, Brunborg G, Kallioniemi O, Andrews PW, Lothe RA, Cancer Res 2005 65 13 5588 5598 (Pubitemid 40911159)
108. CIN By WNT: growth pathways, mitotic control and chromosomal instability in cancer. Hadjihannas MV, Behrens J, Cell Cycle 2006 5 18 2077 2081 (Pubitemid 44553742)
109. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. Terry S, Yang X, Chen M-W, Vacherot F, Buttyan R, J Cell Biochem 2006 99 2 402 410 (Pubitemid 44435558)
110. Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer. Suzuki M, Shigematsu H, Nakajima T, Kubo R, Motohashi S, Sekine Y, Shibuya K, Iizasa T, Hiroshima K, Nakatani Y, Gazdar AF, Fujisawa T, Clin Cancer Res 2007 13 20 6087 6092 (Pubitemid 350075066)
111. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer. Zardawi SJ, O'Toole SA, Sutherland RL, Musgrove EA, Histol Histopathol 2009 24 3 385 398
112. Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. Li C, Zhang Y, Lu Y, Cui Z, Yu M, Zhang S, Xue X, J Cancer Res Clin Oncol 2011 137 5 771 778
113. Jagged1 expression regulated by Notch3 and Wnt/b-catenin signaling pathways in ovarian cancer. Chen X, Stoeck A, Lee SJ, Shih I-M, Wang MM, Wang T-L, Oncotarget 2010 1 3 210 218
114. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, Ishii N, Dahiya R, Clin Cancer Res 2009 15 18 5678 5687
115. A transcriptional roadmap to the induction of pluripotency in somatic cells. Wang Y, Mah N, Prigione A, Wolfrum K, Andrade-Navarro MA, Adjaye J, Stem Cell Rev 2010 6 2 282 296
116. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, Loh Y-H, Yeo HC, Yeo ZX, Narang V, Govindarajan KR, Leong B, Shahab A, Ruan Y, Bourque G, Sung W-K, Clarke ND, Wei C-L, Ng H-H, Cell 2008 133 6 1106 1117 (Pubitemid 351787745)
117. Control of developmental regulators by Polycomb in human embryonic stem cells. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, Kumar RM, Chevalier B, Johnstone SE, Cole MF, Isono K-i, Koseki H, Fuchikami T, Abe K, Murray HL, Zucker JP, Yuan B, Bell GW, Herbolsheimer E, Hannett NM, Sun K, Odom DT, Otte AP, Volkert TL, Bartel DP, Melton DA, Gifford DK, Jaenisch R, Young RA, Cell 2006 125 2 301 313 (Pubitemid 44313811)
118. The Polycomb complex PRC2 and its mark in life. Margueron R, Reinberg D, Nature 2011 469 7330 343 349
119. The transcriptional foundation of pluripotency. Chambers I, Tomlinson SR, Development 2009 136 14 2311 2322
120. Notch signaling in cancer. Allenspach EJ, Maillard I, Aster JC, Pear WS, Cancer Biol Ther 2002 1 5 466 476
121. Development and cancer: at the crossroads of Nodal and Notch signaling. Strizzi L, Hardy KM, Seftor EA, Costa FF, Kirschmann DA, Seftor REB, Postovit L-M, Hendrix MJC, Cancer Res 2009 69 18 7131 7134
122. Notch signaling in development and cancer. Bolos V, Grego-Bessa J, de la Pompa JL, Endocr Rev 2007 28 3 339 363 (Pubitemid 46984831)
123. [Regulation and mechanism of Notch signaling pathway in small cell lung cancer]. Zhang X-m, Wang J-x, Lei X-g, Cheng H, Wang L-l, Yao G-y, Zhonghua Bing Li Xue Za Zhi 2010 39 2 95 99
124. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Efferson CL, Winkelmann CT, Ware C, Sullivan T, Giampaoli S, Tammam J, Patel S, Mesiti G, Reilly JF, Gibson RE, Buser C, Yeatman T, Coppola D, Winter C, Clark EA, Draetta GF, Strack PR, Majumder PK, Cancer Res 2010 70 6 2476 2484
125. Notch signaling pathway in ovarian cancer. Rose SL, Int J Gynecol Cancer 2009 19 4 564 566
126. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, Ali S, Abbruzzese JL, Gallick GE, Sarkar FH, Cancer Res 2009 69 6 2400 2407
127. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. Vallier L, Alexander M, Pedersen RA, J Cell Sci 2005 118 Pt 19 4495 4509 (Pubitemid 41556347)
128. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Zoller M, Nat Rev Cancer 2011 11 4 254 267
129. TGF-beta signaling in tumor suppression and cancer progression. Derynck R, Akhurst RJ, Balmain A, Nat Genet 2001 29 2 117 129 (Pubitemid 32952643)
130. TGF-beta signaling in cancer - a double-edged sword. Akhurst RJ, Derynck R, Trends Cell Biol 2001 11 11 44 51
131. Smad4-mediated TGF-beta signaling in tumorigenesis. Yang G, Yang X, Int J Biol Sci 2010 6 1 1 8
132. TGFbeta signalling: A complex web in cancer progression. Ikushima H, Miyazono K, Nat Rev Cancer 2010 10 6 415 424
133. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. Qin H, Yu T, Qing T, Liu Y, Zhao Y, Cai J, Li J, Song Z, Qu X, Zhou P, Wu J, Ding M, Deng H, J Biol Chem 2007 282 8 5842 5852 (Pubitemid 47093795)
134. p53 is required for etoposide-induced apoptosis of human embryonic stem cells. Grandela C, Pera MF, Grimmond SM, Kolle G, Wolvetang EJ, Stem Cell Res 2007 1 2 116 128
135. Regulation of ES cell differentiation by functional and conformational modulation of p53. Sabapathy K, Klemm M, Jaenisch R, Wagner EF, Embo J 1997 16 20 6217 6229 (Pubitemid 27458342)
136. Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures. Mizuno H, Spike BT, Wahl GM, Levine AJ, Proceedings of the National Academy of Sciences of the United States of America 2010 107 52 22745 22750
137. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG, Nat Med 2011 17 2 211 215
138. Myc transcription factors: key regulators behind establishment and maintenance of pluripotency. Smith K, Dalton S, Regen Med 2010 5 6 947 959
139. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Kim J, Woo AJ, Chu J, Snow JW, Fujiwara Y, Kim CG, Cantor AB, Orkin SH, Cell 2010 143 2 313 324
140. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. Kidder BL, Yang J, Palmer S, PLoS One 2008 3 12 3932
141. myc maintains embryonic stem cell pluripotency and self-renewal. Varlakhanova NV, Cotterman RF, deVries WN, Morgan J, Donahue LR, Murray S, Knowles BB, Knoepfler PS, Differentiation 2010 80 1 9 19
142. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo ABH, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RDG, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SKW, Olsson C, Otonkoski T, Park K-Y, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RAR, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W, Nat Biotechnol 2007 25 7 803 816 (Pubitemid 47052190)
143. A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas. Assou S, Le Carrour T, Tondeur S, Strom S, Gabelle A, Marty S, Nadal L, Pantesco V, Reme T, Hugnot J-P, Gasca S, Hovatta O, Hamamah S, Klein B, De Vos J, Stem Cells 2007 25 4 961 973 (Pubitemid 46572593)
144. Germ cell cancer. Oliver RT, Curr Opin Oncol 1999 11 3 236 241
145. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Chiou S-H, Wang M-L, Chou Y-T, Chen C-J, Hong C-F, Hsieh W-J, Chang H-T, Chen Y-S, Lin T-W, Hsu H-S, Wu C-W, Cancer research 2010 70 24 10433 10444
146. Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. Garcia P, Clarke M, Vegiopoulos A, Berlanga O, Camelo A, Lorvellec M, Frampton J, Embo J 2009 28 10 1492 1504
147. B-MYB is essential for normal cell cycle progression and chromosomal stability of embryonic stem cells. Tarasov KV, Tarasova YS, Tam WL, Riordon DR, Elliott ST, Kania G, Li J, Yamanaka S, Crider DG, Testa G, Li RA, Lim B, Stewart CL, Liu Y, Van Eyk JE, Wersto RP, Wobus AM, Boheler KR, PLoS One 2008 3 6 2478
148. New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer. Stenman G, Andersson MK, Andren Y, Cell cycle (Georgetown, Tex) 2010 9 15 2986 2995
149. MYB function in normal and cancer cells. Ramsay RG, Gonda TJ, Nat Rev Cancer 2008 8 7 523 534 (Pubitemid 351881853)
150. The E2F transcription factors: key regulators of cell proliferation. Muller H, Helin K, Biochim Biophys Acta 2000 1470 1 1 12
151. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Olsson AY, Feber A, Edwards S, Te Poele R, Giddings I, Merson S, Cooper CS, Oncogene 2007 26 7 1028 1037
152. A PANorama of PAX genes in cancer and development. Robson EJD, He S-J, Eccles MR, Nat Rev Cancer 2006 6 1 52 62 (Pubitemid 43053651)
153. Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway. Bokobza SM, Ye L, Kynaston HG, Jiang WG, Oncol Rep 2010 24 6 1653 1659
154. Mining for JAK-STAT mutations in cancer. Constantinescu SN, Girardot M, Pecquet C, Trends in biochemical sciences 2008 33 3 122 131
155. Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: Transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. Katoh Y, Katoh M, International journal of oncology 2007 30 3 751 755
156. MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells. Ren J, Jin P, Wang E, Marincola FM, Stroncek DF, J Transl Med 2009 7 20
157. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Lin S-L, Chang DC, Ying S-Y, Leu D, Wu DTS, Cancer Res 2010 70 22 9473 9482
158. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. Lin S-L, Chang DC, Chang-Lin S, Lin C-H, Wu DTS, Chen DT, Ying S-Y, Rna 2008 14 10 2115 2124
159. miR-302b maintains "stemness" of human embryonal carcinoma cells by post-transcriptional regulation of Cyclin D2 expression. Lee NS, Kim JS, Cho WJ, Lee MR, Steiner R, Gompers A, Ling D, Zhang J, Strom P, Behlke M, Moon S-H, Salvaterra PM, Jove R, Kim K-S, Biochemical and biophysical research communications 2008 377 2 434 440
160. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression. Murray MJ, Saini HK, van Dongen S, Palmer RD, Muralidhar B, Pett MR, Piipari M, Thornton CM, Nicholson JC, Enright AJ, Coleman N, Mol Cancer 2010 9 290
161. Human embryonic stem cells express a unique set of microRNAs. Suh M-R, Lee Y, Kim JY, Kim S-K, Moon S-H, Lee JY, Cha K-Y, Chung HM, Yoon HS, Moon SY, Kim VN, Kim K-S, Dev Biol 2004 270 2 488 498 (Pubitemid 38748567)
162. MicroRNA expression pattern of undifferentiated and differentiated human embryonic stem cells. Lakshmipathy U, Love B, Goff LA, Jornsten R, Graichen R, Hart RP, Chesnut JD, Stem Cells Dev 2007 16 6 1003 1016
163. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ, Nat Cell Biol 2008 10 5 593 601 (Pubitemid 351627379)
164. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RAR, Lao K, Clarke MF, Cell 2009 138 3 592 603
165. Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells. Vallejo DM, Caparros E, Dominguez M, Embo J 2011 30 4 756 769
166. MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries. Bar M, Wyman SK, Fritz BR, Qi J, Garg KS, Parkin RK, Kroh EM, Bendoraite A, Mitchell PS, Nelson AM, Ruzzo WL, Ware C, Radich JP, Gentleman R, Ruohola-Baker H, Tewari M, Stem Cells 2008 26 10 2496 2505
167. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E, Agami R, Nat Cell Biol 2008 10 2 202 210 (Pubitemid 351194050)
168. hsa-miR-520h downregulates ABCG2 in pancreatic cancer cells to inhibit migration, invasion, and side populations. Wang F, Xue X, Wei J, An Y, Yao J, Cai H, Wu J, Dai C, Qian Z, Xu Z, Miao Y, Br J Cancer 2010 103 4 567 574
169. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46. Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, Zhang X, Ye L, Cancer Biol Ther 2010 10 3 232 241
170. miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8. Hu N, Zhang J, Cui W, Kong G, Zhang S, Yue L, Bai X, Zhang Z, Zhang W, Zhang X, Ye L, J Biol Chem 2011 286 15 13714 13722
171. Comprehensive microRNA profiling reveals a unique human embryonic stem cell signature dominated by a single seed sequence. Laurent LC, Chen J, Ulitsky I, Mueller F-J, Lu C, Shamir R, Fan J-B, Loring JF, Stem Cells 2008 26 6 1506 1516
172. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu A-L, Zhao Y, McDonald H, Zeng T, Hirst M, Eaves CJ, Marra MA, Genome research 2008 18 4 610 621 (Pubitemid 351482785)
173. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells. Li X, Pan Y-Z, Seigel GM, Hu Z-H, Huang M, Yu A-M, Biochem Pharmacol 2011 81 6 783 792
174. miR-519 suppresses tumor growth by reducing HuR levels. Abdelmohsen K, Kim MM, Srikantan S, Mercken EM, Brennan SE, Wilson GM, Cabo Rd, Gorospe M, Cell cycle (Georgetown, Tex) 2010 9 7 1354 1359
175. The let-7 family of microRNAs. Roush S, Slack FJ, Trends in cell biology 2008 18 10 505 516
176. Biology of the Mi-2/NuRD Complex in SLAC (Stemness, Longevity/Ageing, and Cancer). Zhang Y, Gene Regul Syst Bio 2011 5 1 26
177. How stem cells age and why this makes us grow old. Sharpless NE, DePinho RA, Nat Rev Mol Cell Biol 2007 8 9 703 713 (Pubitemid 47312828)
178. Aging and replicative senescence have related effects on human stem and progenitor cells. Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, Benes V, Blake J, Huber F-X, Eckstein V, Boukamp P, Ho AD, PLoS One 2009 4 6 5846